POPULATION PHARMACOKINETIC EVALUATION OF INFLIXIMAB REVEALS PATIENT FACTORS THAT INCREASE INFLIXIMAB CLEARANCE AND SHORTEN HALF-LIFE IN INFLAMMATORY BOWEL DISEASE PATIENTS

Iris Dotan  1     Henit Yanai  1     Stuart Becker  1     Sigal Fishman  1     Lior Yahav  1     Merav Ben Yehoyada  1     Diane R. Mould  2    
1 TEL AVIV SOURASKY MEDICAL CENTER
2 Projections Research Inc

Session
IBD III

Conference
UEG Week 2013

Citation
United European Gastroenterology Journal; 2013: 1 (Supplement 1) A513


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing